Strides gains injection approval
BUFFALO GROVE -- Akorn-Strides LLC on Tuesday announced the Food and Drug Administration's approval of an application for Tobramycin Injection USP. The approval demonstrates that a generic drug is bioequivalent to the brand-name product. Tobramycin Injection is an antibiotic and is recommended in the treating of infections that are strongly suspected to be caused by susceptible bacteria.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.